Relation of serum leptin and insulin-like growth factor-1 levels to intima-media thickness and functions of common carotid artery in children and adolescents with type 1 diabetes

Acta Paediatrica, International Journal of Paediatrics

Volumn 93, Issue 8, 2004, Pages 1052-1057

  Atabek, M E ^a   Kurtoglu, S ^b   Demir, F ^b   Baykara, M ^b  

^a SELCUK UNIVERSITY   (Turkey)

^b ERCIYES UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Common carotid artery; IGF 1; Leptin; Type 1 diabetes

Indexed keywords

LEPTIN; SOMATOMEDIN C;

ADOLESCENT; ADULT; ANTHROPOMETRIC PARAMETERS; ARTERY COMPLIANCE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CHILD; CLINICAL ARTICLE; COMMON CAROTID ARTERY; COMPARATIVE STUDY; DISEASE ASSOCIATION; DISEASE DURATION; ECHOGRAPHY; FEMALE; HORMONE DETERMINATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEX DIFFERENCE; YOUNG MODULUS;

ADOLESCENT; ADULT; ARTERIOSCLEROSIS; CAROTID ARTERY, COMMON; CHILD; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; LINEAR MODELS; MALE; MULTIVARIATE ANALYSIS; TUNICA INTIMA; ULTRASONOGRAPHY, DOPPLER;

EID: 7544234621     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035250410031323     Document Type: Article

References (26)

1. Borch-Johnsen K, Kreiner S. Proteinuria: value as predictor of cardio-vascular mortality in insulin dependent diabetes mellitus. Br Med J 1987; 294: 1651-4
2. Parikb A, Socbett EB, McCrindle BW, Dipeband A, Daneman A, Daneman D. Carotid artery distensibility and cardiac function in adolescents type 1 diabetes. J Pediatr 2000; 37: 465-9
3. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevold-sen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219-26
4. Bodary PF, Westrick RJ, Wickenheiser KJ, Shen Y, Eitzman DT. Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA 2002; 287: 1706-9
5. Kiess W, Anil M, Blum WF, Englaro P, Juul A, Attanasio A, et al. Serum leptin levels in children and adolescents with insulin-dependent diabetes mellitus in relation to metabolic control and body mass index. Eur J Endocrinol 1998; 138: 501-9
6. Dunger DB, Cheetham TD, Holly JMP, Matthews DR. Does recombinant insulin-like growth factor I have a role in the treatment of insulin-dependent diabetes mellitus during adolescence? Acta Paediatrica 1993; 388: 49-52
7. Merimee TJ. The interface between diabetic retinopathy, diabetes management, and insulin-like growth factors. J Clin Endocrinol Metab 1997; 82: 2806-7
8. Brown DL, Kane CD, Chernausek SD, Greenhalgh DG. Differential expression and localization of insulin-like growth factors I and II in cutaneous wounds of diabetic and nondiabetic mice. Am J Pathol 1997; 151: 715-24
9. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 6: 1399-1406
10. Aggoun Y, Bonnet D, Sidi D, Girardet JP, Brucker E, Polak M, et al. Arterial mechanical changes in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2000; 20: 2070-5
11. Aggoun Y, Sidi D, Levy BI, Lyonnet S, Kachaner J, Bonnet D. Mechanical properties of the common carotid artery in Williams syndrome. Heart 2000; 84: 290-3
12. Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, et al. Magnitude and deter-minants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 1987; 59: 750-5
13. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. JAMA 1990; 264: 3018-24
14. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC Study. Am J Epidemiol 1991; 134: 250-6
15. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-32
16. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387: 903-8
17. Kamoda T, Saitoh H, Nakahara S, Inudoh M, Hirano T, Matsui A. Serum leptin and insulin con-centrations in prepubertal lean, obese and insulin-dependent diabetes mellitus children. Clin Endocrinol 1998; 49: 385-9
18. Leyva F, Godsland IF, Ghatei M, Proudler AJ, Aldis S, Walton C, et al. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Atheroscler Thromb Vasc Biol 1998; 18: 928-33
19. Laakso M. Hyperglycemia and cardiovascular disease in type-2 diabetes. Diabetes 1999; 48: 937-42
20. Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990; 336: 285-8
21. Tiell ML, Stemerman MB, Spaet TH. The influence of the pituitary on arterial intimal proliferation in the rat. Circ Res 1978; 42: 644-9
22. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 1995; 95: 2266-74
23. Du J, Delafontaine P. Inhibition of vascular smooth muscle cell growth through antisense transcription of a rat insulin-like growth factor I receptor cDNA. Circ Res 1995; 76: 963-72
24. Bornfeldt KE, Raines EW, Nakano T, Graves LM, Krebs EG, Ross R. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest 1994; 93: 1266-74
25. Haylor J, Singh I, el Nahas AM. Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor I. Kidney Int 1991; 39: 333-5
26. Acerini CL, Patton CM, Savage MO, Kernell A, Westphal O, Dunger DB. Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus. Lancet 1997; 350: 1199-204